Upgrade the taste of peptide-based medical nutrition for recovery

Upgrade the taste of peptide-based medical nutrition for recovery

Taste is everything for patients with little appetite and a high risk of disease-related malnutrition. This is why, at Arla Foods Ingredients, we work continuously to improve the sensory appeal of our whey protein hydrolysates (WPH) for peptide-based medical foods.

Today disease-related malnutrition is an issue for an estimated 30-50% of hospital patients1. The better the taste and texture of medical nutrition, the greater the likelihood that patients will meet requirements for daily nutrient intake. That, in turn, will support better recovery, reduce hospital readmissions and improve quality of life overall.

Our whey protein hydrolysates not only improve the taste and texture of peptide-based foods.     They also make it possible to add more protein from a high-quality source.

The best taste and texture yet
Our best-tasting hydrolysate yet, Lacprodan® DI-3092 is a complete and accessible source of essential  amino acids – important for patients with a compromised ability to digest and absorb nutrients in food.  

When incorporated in medical nutrition applications, the hydrolysate’s mild, milky flavour is matched by a low viscosity, which makes it possible to go higher in protein than most medical food products currently on the market2. A light and appealing texture remains.

Versatile applications, flexible processing
Our ready-to-drink and ready-to-mix beverage application suggestions demonstrate the opportunities to incorporate 10g of protein per 100ml. With its low viscosity guarantee, Lacprodan® DI-3092 is equally suitable for tube feeding applications.

The high processing stability of our whey protein hydrolysate ensures the impeccable standards of food safety and hygiene that vulnerable consumers depend on. Stability through direct and indirect UHT processing gives manufacturers the benefit of extra processing flexibility.

Lacprodan® DI-3092 delivers

  • A very mild taste with low bitterness
  • Extensively hydrolysed, high-quality protein source
  • Low lactose content
  • Suitability for direct or indirect UHT treatment

 


1. World Health Organization. Regional Office for Europe. (‎2023)‎.Disease-related malnutrition: a time for action.World Health Organization. Regional Office for Europe. https://iris.who.int/handle/10665/375033. License: CC BY-NC-SA 3.0 IGO
2. Innova Market Insights